Oscar Health Inc Financials
Oscar Health Inc (OSCR) reported $11.7B in revenue for fiscal year 2025, up 27.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation is decoupled from reported profitability, while low capital spending makes operating cash flow convert almost directly into free cash flow.
In FY2025, the company reported a net loss of-$443M but generated$1.1B from operations and$1.1B in free cash flow, so cash movement—not earnings—was the dominant financial mechanic. Because capital expenditures were only$36M , the cash result appears tied mainly to working-capital or other operating balance changes rather than reinvestment economics.
The earnings trajectory is unstable: operating margin improved from
Liquidity is tighter than the cash balance alone suggests. FY2025 current assets of
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Oscar Health Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Oscar Health Inc has an operating margin of -3.4%, meaning the company loses $3 on every $100 of revenue. This results in a profitability score of 32/100. This is down from 0.6% the prior year.
Oscar Health Inc's revenue surged 27.5% year-over-year to $11.7B, reflecting rapid business expansion. This strong growth earns a score of 92/100.
Oscar Health Inc has a moderate D/E ratio of 0.44. This balance of debt and equity financing earns a leverage score of 62/100.
Oscar Health Inc's current ratio of 0.95 is below the typical benchmark, resulting in a score of 17/100. However, the company holds substantial cash reserves (57% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.
Oscar Health Inc has a free cash flow margin of 9.0%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.
Oscar Health Inc posts a -45.3% return on equity (ROE), meaning it loses $45 for every $100 of shareholders' equity. This results in a returns score of 25/100. This is down from 2.5% the prior year.
Oscar Health Inc scores 1.98, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($9.9B) relative to total liabilities ($5.3B). This signals moderate financial risk that warrants monitoring.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Oscar Health Inc passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Oscar Health Inc reported a net loss of $443.2M while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Oscar Health Inc reported an operating loss of $396.4M against $17.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Oscar Health Inc generated $11.7B in revenue in fiscal year 2025. This represents an increase of 27.5% from the prior year.
Oscar Health Inc's EBITDA was -$367.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 511.0% from the prior year.
Oscar Health Inc reported -$443.2M in net income in fiscal year 2025. This represents a decrease of 1842.5% from the prior year.
Oscar Health Inc earned -$1.69 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 1790.0% from the prior year.
Cash & Balance Sheet
Oscar Health Inc generated $1.1B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 11.4% from the prior year.
Oscar Health Inc held $2.8B in cash against $430.1M in long-term debt as of fiscal year 2025, with $4.9B of liabilities due within a year.
Not reported for fiscal year 2025.
Margins & Returns
Oscar Health Inc's operating margin was -3.4% in fiscal year 2025, reflecting core business profitability. This is down 4.0 percentage points from the prior year.
Oscar Health Inc's net profit margin was -3.8% in fiscal year 2025, showing the share of revenue converted to profit. This is down 4.1 percentage points from the prior year.
Oscar Health Inc's ROE was -45.3% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 47.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Capital Allocation
Oscar Health Inc invested $36.4M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 30.4% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
OSCR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.3B | $11.7B+27.5% | $9.2B+56.5% | $5.9B+47.9% | $4.0B+115.6% | $1.8B+297.3% | $462.8M-5.2% | $488.2M |
| SG&A Expenses | $2.4B | $2.0B+16.8% | $1.8B+23.1% | $1.4B+13.4% | $1.3B+374.4% | $265.1M+59.1% | $166.7M+50.6% | $110.7M |
| Operating Income | $629.7M | -$396.4M-792.1% | $57.3M+124.3% | -$235.6M+60.1% | -$589.9M-8.3% | -$544.5M-35.4% | -$402.3M-55.1% | -$259.4M |
| Interest Expense | $15.9M | $17.6M-25.8% | $23.7M-3.5% | $24.6M+8.8% | $22.6M+379.3% | $4.7M+34.3% | $3.5M | $0 |
| Income Tax | $38.9M | $5.6M-23.3% | $7.3M+121.8% | $3.3M+729.8% | -$523K-161.8% | $846K-19.0% | $1.0M-41.7% | $1.8M |
| Net Income | $550.7M | -$443.2M-1842.5% | $25.4M+109.4% | -$270.7M+55.3% | -$606.3M-5.9% | -$572.6M-40.7% | -$406.8M-55.8% | -$261.2M |
| EPS (Diluted) | — | -$1.69-1790.0% | $0.10+108.2% | -$1.22+57.2% | -$2.85+10.9% | -$3.20 | -$14.16-56.3% | -$9.06 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OSCR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|
| Total Assets | $6.3B+30.7% | $4.8B+34.4% | $3.6B-20.4% | $4.5B+36.3% | $3.3B+46.2% | $2.3B | N/A |
| Current Assets | $4.6B+62.1% | $2.8B-7.1% | $3.1B-25.7% | $4.1B+78.7% | $2.3B+23.3% | $1.9B | N/A |
| Cash & Equivalents | $2.8B+81.7% | $1.5B-18.3% | $1.9B+20.0% | $1.6B+41.2% | $1.1B+33.6% | $826.3M+145.5% | $336.6M |
| Accounts Receivable | $362.7M | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $5.3B+39.8% | $3.8B+36.8% | $2.8B-23.1% | $3.6B+88.4% | $1.9B-45.9% | $3.6B | N/A |
| Current Liabilities | $4.9B+40.4% | $3.5B+42.6% | $2.4B-25.6% | $3.3B+76.2% | $1.9B+11.2% | $1.7B | N/A |
| Long-Term Debt | $430.1M+43.6% | $299.6M+0.3% | $298.8M+0.3% | $298.0M | N/A | $142.5M | N/A |
| Total Equity | $977.6M-3.5% | $1.0B+26.1% | $804.0M-9.7% | $890.4M-35.8% | $1.4B+207.0% | -$1.3B-37.1% | -$945.1M |
| Retained Earnings | -$3.3B-15.5% | -$2.9B+0.9% | -$2.9B-10.4% | -$2.6B-30.3% | -$2.0B-40.1% | -$1.4B | N/A |
Not reported in any period shown, so not listed: Inventory, Goodwill.
OSCR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $4.4B | $1.1B+11.9% | $978.2M+459.4% | -$272.2M-171.6% | $380.3M+309.3% | -$181.7M-181.6% | $222.7M+234.7% | -$165.4M |
| Capital Expenditures | $38.6M | $36.4M+30.4% | $27.9M+9.1% | $25.6M-11.8% | $29.0M+12.1% | $25.9M+84.6% | $14.0M-46.1% | $26.0M |
| Free Cash Flow | $4.4B | $1.1B+11.4% | $950.3M+419.2% | -$297.7M-184.7% | $351.3M+269.2% | -$207.6M-199.5% | $208.7M+209.1% | -$191.4M |
| Investing Cash Flow | -$3.3B | -$241.1M+82.6% | -$1.4B-340.4% | $577.2M+354.8% | -$226.5M+70.8% | -$774.5M-124.7% | -$344.7M-329.0% | $150.5M |
| Financing Cash Flow | $381.9M | $399.2M+483.7% | $68.4M+960.9% | $6.4M-97.9% | $301.1M-75.7% | $1.2B+102.5% | $611.7M+28967.7% | -$2.1M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $3.0M |
Not reported in any period shown, so not listed: Dividends Paid.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
OSCR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.4%-4.0pp | 0.6%+4.6pp | -4.0%+10.9pp | -14.9%+14.7pp | -29.6%+57.3pp | -86.9%-33.8pp | -53.1% |
| Net Margin | -3.8%-4.1pp | 0.3%+4.9pp | -4.6%+10.7pp | -15.3%+15.8pp | -31.1%+56.8pp | -87.9%-34.4pp | -53.5% |
| Return on Equity | -45.3%-47.8pp | 2.5%+36.2pp | -33.7%+34.4pp | -68.1%-26.8pp | -41.3% | N/A | N/A |
| Return on Assets | -7.0%-7.5pp | 0.5%+8.1pp | -7.5%+5.9pp | -13.4%+3.9pp | -17.2%+0.7pp | -17.9% | N/A |
| Current Ratio | 0.95+0.1x | 0.82-0.4x | 1.260.0x | 1.260.0x | 1.24+0.1x | 1.12 | N/A |
| Debt-to-Equity | 0.44+0.1x | 0.30-0.1x | 0.370.0x | 0.33-1.1x | 1.39 | N/A | N/A |
| FCF Margin | 9.0%-1.3pp | 10.3%+15.4pp | -5.1%-13.9pp | 8.9%+20.2pp | -11.3%-56.4pp | 45.1%+84.3pp | -39.2% |
Not reported in any period shown, so not listed: Gross Margin.
Note: The current ratio is below 1.0 (0.95), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Oscar Health Inc Ranks
Frequently Asked Questions
What is Oscar Health Inc's annual revenue?
Oscar Health Inc (OSCR) reported $11.7B in total revenue for fiscal year 2025. This represents a 27.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Oscar Health Inc's revenue growing?
Oscar Health Inc (OSCR) revenue grew by 27.5% year-over-year, from $9.2B to $11.7B in fiscal year 2025.
Is Oscar Health Inc profitable?
No, Oscar Health Inc (OSCR) reported a net income of -$443.2M in fiscal year 2025, with a net profit margin of -3.8%.
What is Oscar Health Inc's EBITDA?
Oscar Health Inc (OSCR) had EBITDA of -$367.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Oscar Health Inc have?
As of fiscal year 2025, Oscar Health Inc (OSCR) had $2.8B in cash and equivalents against $430.1M in long-term debt.
What is Oscar Health Inc's operating margin?
Oscar Health Inc (OSCR) had an operating margin of -3.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Oscar Health Inc's net profit margin?
Oscar Health Inc (OSCR) had a net profit margin of -3.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Oscar Health Inc's return on equity (ROE)?
Oscar Health Inc (OSCR) has a return on equity of -45.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Oscar Health Inc's free cash flow?
Oscar Health Inc (OSCR) generated $1.1B in free cash flow during fiscal year 2025. This represents a 11.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Oscar Health Inc's operating cash flow?
Oscar Health Inc (OSCR) generated $1.1B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Oscar Health Inc's total assets?
Oscar Health Inc (OSCR) had $6.3B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Oscar Health Inc's capital expenditures?
Oscar Health Inc (OSCR) invested $36.4M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Oscar Health Inc's current ratio?
Oscar Health Inc (OSCR) had a current ratio of 0.95 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Oscar Health Inc's debt-to-equity ratio?
Oscar Health Inc (OSCR) had a debt-to-equity ratio of 0.44 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Oscar Health Inc's return on assets (ROA)?
Oscar Health Inc (OSCR) had a return on assets of -7.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Oscar Health Inc's Altman Z-Score?
Oscar Health Inc (OSCR) has an Altman Z-Score of 1.98, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Oscar Health Inc's Piotroski F-Score?
Oscar Health Inc (OSCR) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Oscar Health Inc's earnings high quality?
Oscar Health Inc (OSCR) reported a net loss of $443.2M while generating $1.1B in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Oscar Health Inc cover its interest payments?
Oscar Health Inc (OSCR) reported an operating loss of $396.4M against $17.6M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Oscar Health Inc?
Oscar Health Inc (OSCR) scores 47 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.